{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:41:46Z","timestamp":1788964906595,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T00:00:00Z","timestamp":1441756800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1620-3","type":"journal-article","created":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T12:54:25Z","timestamp":1441803265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Case report of severe Cushing\u2019s syndrome in medullary thyroid cancer complicated by functional diabetes insipidus, aortic dissection, jejunal intussusception, and paraneoplastic dysautonomia: remission with sorafenib without reduction in cortisol concentration"],"prefix":"10.1186","volume":"15","author":[{"given":"Muhammad M.","family":"Hammami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najla","family":"Duaiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazi","family":"Mutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabah","family":"Aklabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser","family":"Qattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohei El-Din M.","family":"Abouzied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed W.","family":"Sous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,9]]},"reference":[{"key":"1620_CR1","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1210\/jc.2009-0612","volume":"94","author":"M Boscaro","year":"2009","unstructured":"Boscaro M, Arnaldi G. Approach to the patient with possible Cushing\u2019s syndrome. J Clin Endocrinol Metab. 2009;94:3121\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1620_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1210\/jc.2005-1542","volume":"91","author":"AM Isidori","year":"2006","unstructured":"Isidori AM, Kaltsas GA, Pozza C, Frajese V, Newell-Price J, Reznek RH, et al. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow up. J Clin Endocrinol Metab. 2006;91(2):371\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1620_CR3","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1210\/jc.2004-2527","volume":"90","author":"I Ilias","year":"2005","unstructured":"Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing\u2019s syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005;90(8):4955\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"1620_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.anndiagpath.2006.08.007","volume":"12","author":"MD Williams","year":"2008","unstructured":"Williams MD, Asa SL, Fuller GN. Medullary thyroid carcinoma metastatic to the pituitary gland: an unusual site of metastasis. Ann Diagn Pathol. 2008;12:199\u2013203.","journal-title":"Ann Diagn Pathol"},{"key":"1620_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/hed.20911","volume":"31","author":"L Santarpia","year":"2009","unstructured":"Santarpia L, Gagel RF, Sherman SI, Sarlis NJ, Evans DB, Hoff AO. Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer. Head Neck. 2009;31:419\u201323.","journal-title":"Head Neck"},{"key":"1620_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1530\/eje.1.02299","volume":"155","author":"V Ba\u00a8hr","year":"2006","unstructured":"Ba\u00a8hr V, Franzen N, Oelkers W, Pfeiffer AFH, Diederich S. Effect of exogenous glucocorticoid on osmotically stimulated antidiuretic hormone secretion and on water reabsorption in man. Eur J Endocrinol. 2006;155:845\u20138.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1620_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1089\/thy.2005.15.618","volume":"15","author":"SL Barbosa","year":"2005","unstructured":"Barbosa SL, Rodien P, Leboulleux S, Niccoli-Sire P, Kraimps JL, Caron P, et al. Ectopic adrenocorticotropic hormone \u2013syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature. Thyroid. 2005;15(6):618\u201323.","journal-title":"Thyroid"},{"key":"1620_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMc1301428","volume":"369","author":"C Baudry","year":"2013","unstructured":"Baudry C, Paepegaey AC, Groussin L. Reversal of Cushing\u2019s syndrome by vandetanib in medullary thyroid carcinoma. N Engl J Med. 2013;369:584\u20136.","journal-title":"N Engl J Med"},{"key":"1620_CR9","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1210\/jc.2013-4340","volume":"99","author":"AA Nella","year":"2014","unstructured":"Nella AA, Lodish MB, Fox E, Balis FM, Quezado MM, Whitcomb PO, et al. Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient. J Clin Endocrinol Metab. 2014;99:3055\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1620_CR10","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1089\/thy.2013.0571","volume":"24","author":"R Barroso-Sousa","year":"2014","unstructured":"Barroso-Sousa R, Lerario AM, Evangelista J, Papadia C, Lourenc Jr DM, Lin CS, et al. Complete resolution of hypercortisolism with sorafenibin a patient with advanced medullary thyroid carcinoma and ectopic ACTH (adrenocorticotropic hormone) syndrome. Thyroid. 2014;24(6):1062\u20136.","journal-title":"Thyroid"},{"key":"1620_CR11","first-page":"50","volume":"1","author":"L Petramala","year":"2009","unstructured":"Petramala L, Cotesta D, Sapienza P, Zinnamosca L, Moroni E, di Marzio L, et al. A case of acute aortic dissection type B associated with Cushing\u2019s syndrome. J Clin Med Res. 2009;1:50\u20132.","journal-title":"J Clin Med Res"},{"issue":"4","key":"1620_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3748\/wjg.15.407","volume":"15","author":"A Marinis","year":"2009","unstructured":"Marinis A, Yiallourou A, Samanides L, Dafnios N, Anastasopoulos G, Vassiliou I, et al. Intussusception of the bowel in adults: A review. World J Gastroenterol. 2009;15(4):407\u201311.","journal-title":"World J Gastroenterol"},{"key":"1620_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJM200009213431204","volume":"343","author":"S Vernino","year":"2000","unstructured":"Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Eng J Med. 2000;343:847\u201355.","journal-title":"N Eng J Med"},{"key":"1620_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0300-2977(98)00051-5","volume":"53","author":"M Castro Cabezas","year":"1998","unstructured":"Castro Cabezas M, Vrinten DH, Burgers JA, Croughs RJM. Central diabetes insipidus and Cushing\u2019s syndrome due to ectopic ACTH production by disseminated small cell lung cancer: A case report. Neth J Med. 1998;53:32\u20136.","journal-title":"Neth J Med"},{"issue":"2","key":"1620_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11102-005-3308-1","volume":"8","author":"A Agha","year":"2005","unstructured":"Agha A, Brennan S, Moore KB, Grogan L, Thompson CJ. Small-Cell lung cancer presenting as diabetes insipidus and Cushing\u2019s syndrome. Pituitary. 2005;8(2):105\u20137.","journal-title":"Pituitary"},{"key":"1620_CR16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1530\/eje.0.1460789","volume":"146","author":"M Quinkler","year":"2002","unstructured":"Quinkler M, Meyer B, Bumke-Vogt C, Grossmann C, Gruber U, Oelkers W, et al. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor. Eur J Endocrinol. 2002;146:789\u2013800.","journal-title":"Eur J Endocrinol"},{"issue":"6\u20137","key":"1620_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.steroids.2007.03.012","volume":"72","author":"S Zhang","year":"2007","unstructured":"Zhang S, Jonklaas J, Danielsen M. The glucocorticoid agonist activities of mifepristone (RU486) and progesterone are dependent on glucocorticoid receptor concentrations but not on EC50 values. Steroids. 2007;72(6\u20137):600\u20138.","journal-title":"Steroids"},{"key":"1620_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1472-6890-14-33","volume":"14","author":"MD Krasowski","year":"2014","unstructured":"Krasowski MD, Drees D, Morris CS, Maakestad J, Blau JL, Ekins S. Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimentional molecular similarity prediction. BMC Clin Pathol. 2014;14:33.","journal-title":"BMC Clin Pathol"},{"key":"1620_CR19","doi-asserted-by":"publisher","first-page":"11530","DOI":"10.3390\/ijms130911530","volume":"13","author":"F Zengerling","year":"2012","unstructured":"Zengerling F, Streicher W, Schrader AJ, Schrader M, Nitzsche B, Cronauer MV, et al. Effects of sorafenib on C-terminally truncated androgen receptor variants in human prostate cancer cells. Int J Mol Sci. 2012;13:11530\u201342.","journal-title":"Int J Mol Sci"},{"key":"1620_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3803\/EnM.2014.29.2.202","volume":"29","author":"SW Lee","year":"2014","unstructured":"Lee SW, Lee EK, Yun T, Won YW, Ko EJ, Choi M, et al. Recurrent hypoglycemia triggered by sorafenib therapy in a patient with hemangiopericytoma. Endocrinol Metab. 2014;29:202\u20135.","journal-title":"Endocrinol Metab"},{"key":"1620_CR21","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","volume":"332","author":"VA Lennon","year":"1995","unstructured":"Lennon VA, Kryzer GE, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med. 1995;332:1467\u201374.","journal-title":"N Engl J Med"},{"key":"1620_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jneuroim.2008.05.025","volume":"201\u2013202","author":"MJ Titulaer","year":"2008","unstructured":"Titulaer MJ, Wirtz PW, Kuks JB, Schelhaas HJ, van der Kooi AJ, Faber CG, et al. The Lambert-Eaton myasthenic syndrome 1988\u20132008: A clinical picture in 97 patients. J Neuroimmunol. 2008;201\u2013202:153\u20138.","journal-title":"J Neuroimmunol"},{"key":"1620_CR23","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.clinph.2013.02.115","volume":"124","author":"C Crone","year":"2013","unstructured":"Crone C, Christiansen I, Vissing J. Myopathic EMG findings and type II muscle fiber atrophy in patients with Lambert-Eaton myasthenic syndrome. Clin Neurophysiol. 2013;124:1889\u201392.","journal-title":"Clin Neurophysiol"},{"issue":"3","key":"1620_CR24","first-page":"173","volume":"41","author":"M Jin","year":"2020","unstructured":"Jin M, Khan AI. Procalcitonin: Uses in the clinical laboratory for the diagnosis of sepsis. Labmed. 2020;41(3):173\u20137.","journal-title":"Labmed"},{"issue":"2","key":"1620_CR25","first-page":"169","volume":"21","author":"K Kaczka","year":"2012","unstructured":"Kaczka K, Mikosinski S, Fendker W, Celnik A, Pomorski L. Calcitonin and procalcitonin in patients with medullary thyroid cancer or bacterial infection. Adv Cli Exp Med. 2012;21(2):169\u201378.","journal-title":"Adv Cli Exp Med"},{"issue":"19","key":"1620_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4037\/ajcc2009805","volume":"1","author":"J Schumm","year":"2010","unstructured":"Schumm J, Pfeifer R, Ferrari M, Kuethe F, Figulla HR. An unusual case of progressive shock and highly elevated procalcitonin concentration. Am J Crit Care. 2010;1(19):96\u20133.","journal-title":"Am J Crit Care"},{"key":"1620_CR27","doi-asserted-by":"publisher","first-page":"E863","DOI":"10.1210\/jc.2010-1921","volume":"96","author":"MM Moura","year":"2011","unstructured":"Moura MM, Cavaco BM, Pinto AE, Leite V. High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas. J Clin Endocrinol Metab. 2011;96:E863\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1620_CR28","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1200\/JCO.2009.25.0068","volume":"28","author":"ET Lam","year":"2010","unstructured":"Lam ET, Ringel MD, Kloos RT, Prior TW, Knopp MV, Liang J, et al. Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer. J Clin Oncol. 2010;28:2323\u201330.","journal-title":"J Clin Oncol"},{"key":"1620_CR29","doi-asserted-by":"crossref","unstructured":"Gorospe EC and Badamas J. Acute liver failure secondary to metastaic medullary thyroid cancer. Case Report in Hepatology. Volume 2011, Article ID 603757, 4 pages. Doi:10.1155\/2011\/603757.","DOI":"10.1155\/2011\/603757"},{"key":"1620_CR30","doi-asserted-by":"crossref","unstructured":"Van Hootegem A, Verslype C, Van Steenbergen W. Sorafenib-induced liver failure: A case report and review of the literature. Case Reports in Hepatology Volume 2011, Article ID 941395, 4 pages.","DOI":"10.1155\/2011\/941395"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1620-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1620-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1620-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T08:57:27Z","timestamp":1567155447000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1620-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,9]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1620"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1620-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,9]]},"article-number":"624"}}